Author Interviews, Heart Disease, Ophthalmology, Stem Cells / 07.06.2021
Youthful Biochemical Signals in Amniotic Fluid Can Be Used to Repair Aging Tissues
MedicalResearch.com Interview with:
[caption id="attachment_57572" align="alignleft" width="143"]
Dr. Ian White[/caption]
Ian A. White, M.S., Ph.D.
Founder, President & Chief Scientific Officer
Neobiosis, LLC
Interdisciplinary Stem Cell Institute
University of Miami
MedicalResearch.com: What is the mission of Stem Cell Institute and Neobiosis?
The Interdisciplinary Stem Cell Institute at the University of Miami was established to capitalize on pioneering work in the use of adult stem cells for the repair of malfunctioning human organs. The goal of the Institute is to find new treatments for heart disease, neurological disease, bone disease, diabetes, cancer, eye diseases, and other chronic, debilitating, or incurable diseases.
Neobiosis is a privately-owned biotech company dedicated to the manufacture and development of regenerative tissues, cells, and the secretome from perinatal sources. Our mission is to provide high-quality products for research and clinical trials by focusing on the science of regenerative medicine.
Dr. Ian White[/caption]
Ian A. White, M.S., Ph.D.
Founder, President & Chief Scientific Officer
Neobiosis, LLC
Interdisciplinary Stem Cell Institute
University of Miami
MedicalResearch.com: What is the mission of Stem Cell Institute and Neobiosis?
The Interdisciplinary Stem Cell Institute at the University of Miami was established to capitalize on pioneering work in the use of adult stem cells for the repair of malfunctioning human organs. The goal of the Institute is to find new treatments for heart disease, neurological disease, bone disease, diabetes, cancer, eye diseases, and other chronic, debilitating, or incurable diseases.
Neobiosis is a privately-owned biotech company dedicated to the manufacture and development of regenerative tissues, cells, and the secretome from perinatal sources. Our mission is to provide high-quality products for research and clinical trials by focusing on the science of regenerative medicine.
Dr. Reed[/caption]
Nicholas S. Reed, AuD
Assistant Professor | Department of Epidemiology
Core Faculty | Cochlear Center for Hearing and Public Health
Johns Hopkins University Bloomberg School of Public Health
MedicalResearch.com: What is the background for this study?
Response: It is known that hearing aid ownership is relatively low in the United States at less than 20% of adults with hearing loss owning and using hearing aids. However, many national estimates of hearing aid ownership are based on data that is over 10 years old. Our team was interested in trying to understand whether ownership in hearing aids had changed over time. We used data from 2011 to 2018 in a nationally representative (United States) observational cohort (The National Health and Aging Trends Study) of Medicare Beneficiaries aged 70 years and older to estimate the change in hearing aid ownership.
In our analysis, the proportion of Medicare beneficiaries 70 years and older who reported owning and using their hearing aids increased 23.3% from 2011 to 2018. However, this growth in ownership was not equal across all older adults. For example, while White males saw a 28.7% increase in hearing aid ownership, Black females saw only a 5.8% increase over the same 8-year period. Moreover, adults living at less than 100% federal poverty level actually saw an overall 13.0% decrease in hearing aid ownership while those living at more than 200% federal poverty line saw an overall 30.6% increase.
Dr. Rosi[/caption]
Susanna Rosi, Ph.D.
Lewis and Ruth Cozen Chair II
Prof.l Tower[/caption]
John Gerard Tower
Professor of biological sciences
University of Southern California
MedicalResearch.com: What is the background for this study?
Response: Mifepristone is a synthetic steroid drug that is used in humans for birth control and as a treatment for Cushing’s disease, and is currently in clinical trials as an anti-cancer treatment.
We have previously shown that mifepristone dramatically increases the life span of mated female Drosophila flies.
Dr. Zhang[/caption]
Ruiyuan Zhang, MD, MS
Department of Epidemiology and Biostatistics
University of Georgia College of Public Health
Athens, Georgia
MedicalResearch.com: What is the background for this study?
Response: Although there are several studies that focused on the effect of alcohol drinking on cognitive function, their findings were still mixed. So we want to use some new analysis techniques on this topic to see if we can have new findings.
MedicalResearch.com: What are the main findings?
Response: The main finding of our study is that low-to-moderate alcohol drinking is associated with better cognitive function outcomes.


Dr. Cohen[/caption]
Pieter A. Cohen, MD
Department of Medicine, Cambridge Health Alliance
Somerville, Massachusetts
Harvard Medical School
Boston, Massachusetts
MedicalResearch.com: What is the background for this study?
Response: There has been increasing interest in the use of over-the-counter supplements to help improve memory and cognitive function. However, prior
